Lady Davis Institute Distinguished Lecture Series: Sabine Mai, Ph.D.

Lady Davis Institute / Online

What nuclear architecture tells us about the cancer genome

Prof. Sabine Mai

Sabine Mai, Ph.D.

Tier I Canada Research Chair in Genomic Instability and Nuclear Architecture in Cancer
Professor, Physiology and Pathophysiology, Biochemistry & Medical Genetics, Human Anatomy and Cell Science, University of Manitoba
Director, The Genomic Centre for Cancer Research and Diagnosis (GCCRD)
Senior Investigator, Cell Biology, CancerCare Manitoba Research

Tuesday, November 9, 2021
10:45 am – 12:00 pm – HYBRID EVENT
Block B Amphitheater B-106 (JGH, Pavilion B)
3755, Côte-Ste-Catherine Road, Mtl, QC H3T 1E2

Webinar ID: 815 2545 6297
Passcode: 236632
Join event

Dr. Sabine Mai completed her Ph.D. at the University of Karlsruhe in Germany, where she studied the DNA damage response in mammalian cells before joining the Basel Institute of Immunology in Switzerland as a postdoctoral fellow. There, she made seminal discoveries related to the contribution of c-Myc in promoting genomic instability. In 1995, Dr. Mai was recruited as an Assistant Professor at the University of Manitoba, where she opened her laboratory to study genomic instability in cancer cells, in particular how the three-dimensional organization of the mammalian nucleus is impacted by c-Myc deregulation. Dr. Mai is currently Professor of Physiology and Pathophysiology, Biochemistry and Medical Genetics, Human Anatomy and Cell Science at the University of Manitoba and a Senior Investigator at the CancerCare Manitoba Research Institute in Winnipeg. She is also the Director of the Genomic Centre for Cancer Research and Diagnosis (GCCRD), a cutting-edge – multi-user imaging facility that she established. She was awarded a Canada Research Chair (Tier 1) in 2018 in Genomic Instability and Nuclear Architecture in Cancer and is one of Canada’s Most Powerful Women: Top 100 Award Winners in 2015. Importantly, her career goal has been to understand mechanisms of cancer initiation and progression and translate this knowledge to improve cancer patient care.

Host: Dr. Alexandre Orthwein (514) 340-8222 x24252 / e-mail:


Copyright © 2019 McGill Regenerative Medicine Network. All rights reserved. Website by KORSR Studio, Valérie Provost & ER5.